Early linezolid-associated lactic acidosis in a patient treated for tuberculous spondylodiscitis.
Scotton
P
P
Fuser
R
R
Torresan
S
S
Carniato
A
A
Giobbia
M
M
Rossi
C
C
Inojosa
W O
WO
Vaglia
A
A
D000081:Acetamides / Q000009:adverse effects* / Q000627:therapeutic use*; D000140:Acidosis, Lactic / Q000139:chemically induced* / Q000628:therapy; D000369:Aged, 80 and over; D000890:Anti-Infective Agents / Q000009:adverse effects*; D015299:Discitis / Q000188:drug therapy* / Q000382:microbiology; D005260:Female; D006801:Humans; D000069349:Linezolid; D008159:Lumbar Vertebrae / Q000382:microbiology / Q000473:pathology; D009169:Mycobacterium tuberculosis / Q000302:isolation & purification; D023303:Oxazolidinones / Q000009:adverse effects* / Q000627:therapeutic use*; D016896:Treatment Outcome; D014376:Tuberculosis / Q000188:drug therapy* / Q000382:microbiology / Q000473:pathology
D000081:Acetamides; D000890:Anti-Infective Agents; D023303:Oxazolidinones; D000069349:Linezolid